147 related articles for article (PubMed ID: 16336424)
21. Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
Turco MA; Ormiston JA; Popma JJ; Mandinov L; O'Shaughnessy CD; Mann T; McGarry TF; Wu CJ; Chan C; Webster MW; Hall JJ; Mishkel GJ; Cannon LA; Baim DS; Koglin J
J Am Coll Cardiol; 2007 Apr; 49(16):1676-83. PubMed ID: 17448368
[TBL] [Abstract][Full Text] [Related]
22. Procedural success and 30 day outcomes between CYPHER and TAXUS stent implantation for the treatment of bifurcation lesions--a single-center experience.
Lee CH; Tan HC; Bee H; Zhang JJ; Soon CY; Teo SG; Low A; Lim YT
J Invasive Cardiol; 2006 Feb; 18(2):39-42. PubMed ID: 16446512
[TBL] [Abstract][Full Text] [Related]
23. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
[TBL] [Abstract][Full Text] [Related]
24. Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease.
Jensen LO; Thayssen P; Tilsted HH; Ravkilde J; Junker A; Hansen HS; Hansen KN; Pedersen KE; Sørensen HT; Thuesen L; Lassen JF;
Cardiology; 2010; 116(2):73-8. PubMed ID: 20523042
[TBL] [Abstract][Full Text] [Related]
25. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
[TBL] [Abstract][Full Text] [Related]
26. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW
Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
[TBL] [Abstract][Full Text] [Related]
28. Update on drug-eluting coronary stents.
Kipshidze NN; Tsapenko MV; Leon MB; Stone GW; Moses JW
Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):953-68. PubMed ID: 16181039
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Stone GW; Suryapranata H; Laarman GJ; Menichelli M; Kaiser C; Valgimigli M; Di Lorenzo E; Dirksen MT; Spaulding C; Pittl U; Violini R; Percoco G; Marino P
Int J Cardiol; 2009 Apr; 133(2):213-22. PubMed ID: 18394731
[TBL] [Abstract][Full Text] [Related]
30. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
[TBL] [Abstract][Full Text] [Related]
31. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
[TBL] [Abstract][Full Text] [Related]
32. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
Beijk MA; Piek JJ
Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
[TBL] [Abstract][Full Text] [Related]
33. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
Perin EC
Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
[TBL] [Abstract][Full Text] [Related]
34. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.
Kandzari DE; Leon MB; Popma JJ; Fitzgerald PJ; O'Shaughnessy C; Ball MW; Turco M; Applegate RJ; Gurbel PA; Midei MG; Badre SS; Mauri L; Thompson KP; LeNarz LA; Kuntz RE;
J Am Coll Cardiol; 2006 Dec; 48(12):2440-7. PubMed ID: 17174180
[TBL] [Abstract][Full Text] [Related]
35. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
Mehilli J; Kastrati A; Wessely R; Dibra A; Hausleiter J; Jaschke B; Dirschinger J; Schömig A;
Circulation; 2006 Jan; 113(2):273-9. PubMed ID: 16391155
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
[TBL] [Abstract][Full Text] [Related]
38. The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus Taxus.
Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Colombo A
J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):2-4. PubMed ID: 16645353
[No Abstract] [Full Text] [Related]
39. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
Grube E; Dawkins KD; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Buellesfeld L; Koglin J; Russell ME
Eur Heart J; 2007 Nov; 28(21):2578-82. PubMed ID: 17938126
[TBL] [Abstract][Full Text] [Related]
40. [The incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease in the real world: a single center registry study].
Chen JL; Yang YJ; Huang JH; Qin XW; Qiao SB; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Dec; 35(12):1133-5. PubMed ID: 18341817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
